SlideShare a Scribd company logo
1 of 1
Assessment of Six1 Expression in Mouse Mammary Tumor Cells
Reina Hernandez; Mentor, Michael Cantrell; P.I. Dr. Carla Van Den Berg
College of Pharmacy, The University of Texas at Austin
Abstract
Six 1 is a homeoprotein overexpressed in numerous
cancers, where it plays a role in Epithelial-Mesenchymal
Transition (EMT) and metastasis. Six1 expression is
increased by JNK2 (c-Jun N-terminal kinase 2). Together;
JNK2 promotes EMT and Six1 expression in breast
cancer cell lines. To determine whether transforming
growth factor beta (TGFß) activates JNK2 to increase
Six1 expression, cell culture experiments were completed
throughout a 24, 48, and 72 hour period. P53: jnk2ko
GFP-JNK2 cancer cells were treated with serum free
media alone or with TGFß, fetal bovine serum, and
fibroblast growth factor-alpha added. Throughout the 24-
48 hour period, cells were harvested and Western blot
analysis was used to determine the protein expression of
Six1. Growth of mouse mammary tumor cells was seen in
a 24 to 72 hour period, and changes in morphology were
noted. PCR was also completed to establish a standard
curve that could be used in future qPCR experiments
using samples from the Six1 cell culture experiments.
Unexpectedly, multiple bands showed that there may be
changes in Six1 phosphorylation in addition to potential
expression differences. To better understand the
mechanisms behind Six1 expression and JNK2, further
experiments are required.
(1) Six1 expression cell culture experiments completed throughout a 24, 48, and 72 hour period. P53:jnk2ko GFP-JNK2 cancer cells were treated with
SFM, TGFß, 10%FBS, and ∂FGF. Increased proliferation of mouse mammary tumor cells are seen in the 24-72 hour period. Cells in 24-hour samples are
cuboidal; by contrast cells in 72-hour samples are more spindle shaped morphology and are not contact inhibited in the TGFβ sample. (3,4,5) Western blot
analysis of 24-72 hour period of P53: jnk2ko GFP-JNK2 cells was completed and tested with Beta-Tubulin as a loading control. Unexpectedly, we observed
that Six1 protein migrates as multiple bands in some treatments, indicating that it may be phosphorylated in proliferating cells. The presence of multiple
bands prevented accurate quantification of total Six1 protein expression (2,6) Figure 2. PCR that was completed on Six1. This experiment resulted in an
optimum annealing temperature 52-53.5 degrees that was used to construct a standard curve with varying concentrations by future qPCR experiments.
Results
Results ContinuedMethods
1.
2.
3.
6.
4.
Conclusion/Discussion
While changes in Six1 protein expression was not
determined, we did observed that Six1 undergoes post-
tranlastional changes consistent with phosphorylation in
response to growth factor treatments. Human Six1 has
been demonstrated as “a nuclear phosphoprotein that
becomes hyperphosphorylated at mitosis.” (Ford, et. al.
2000) This can account for the multiple Six1 bands in
response to treatment. We also observed a change in
cell morphology. Mouse mammary tumor cells from the
24-hour period were cuboidal, by comparison to the 72
hour treated cells, which appear more spindle-like,
consistent with EMT. PCR optimization provided ideal
annealing temperatures that will be used to construct a
standard curve for qPCR experiments. Six1 and JNK2’s
role in the events leading to EMT will be tested using
jnk2 knockout cells.
Introduction
There are three c-Jun N-terminal kinase (jnk) genes
(jnk1-3) that are expressed in mice and humans. The Van
Den Berg lab studies JNK2 breast cancer, and have
previously shown that JNK2 regulates Epithelial to
Mesenchymal Transition (EMT) and Six1, a regulator of
EMT. Because TGFß promotes Six1 expression, we
hypothesized that EMT is induced through the pathway
as shown in Figure 1.
Acknowledgements
This project was supported by The University of Texas
System Louis Stokes Alliance for Minority Participation
(LSAMP) and funded by The National Science
Foundation
Special thanks to Dr. Van Den Berg and to all members
of the Van Den Berg Lab
Figure 1.
5.
References
Heide L. Ford, Esther Landesman-Bollag, Caroline S.
Dacwag, P. Todd Stukenberg, Arthur B. Pardee, and
David C. Seldin. “Cell Cycle-regulated Phosphorylation
of the Human SIX1 Homeodomain Protein.” JBC Papers
(2000). DOI 10.1074/jbc. M002446200

More Related Content

What's hot

Modeling Myc Inhibition In Vitro [Poster]
Modeling Myc Inhibition In Vitro [Poster]Modeling Myc Inhibition In Vitro [Poster]
Modeling Myc Inhibition In Vitro [Poster]
Alexander Yu
 
FinalMethodology.docx
FinalMethodology.docxFinalMethodology.docx
FinalMethodology.docx
InfoEric33
 
Guidelines and techniques for iPSC
Guidelines and techniques for iPSCGuidelines and techniques for iPSC
Guidelines and techniques for iPSC
lihuaibei
 
Maslak p.g.-et-al.-2010-blood
Maslak p.g.-et-al.-2010-bloodMaslak p.g.-et-al.-2010-blood
Maslak p.g.-et-al.-2010-blood
SellasCorp
 
AACR poster VP_2014
AACR poster VP_2014AACR poster VP_2014
AACR poster VP_2014
Victor Prima
 

What's hot (20)

Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer  ddw2016Tgr5 and gastric cancer  ddw2016
Tgr5 and gastric cancer ddw2016
 
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that ...
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that ...Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that ...
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that ...
 
440
440440
440
 
Antibody Customer Review for TWIST1 Polyclonal Antibody (STJ31126)
Antibody Customer Review for TWIST1 Polyclonal Antibody (STJ31126)Antibody Customer Review for TWIST1 Polyclonal Antibody (STJ31126)
Antibody Customer Review for TWIST1 Polyclonal Antibody (STJ31126)
 
Im vacs 2015 rennert v2
Im vacs 2015 rennert v2Im vacs 2015 rennert v2
Im vacs 2015 rennert v2
 
Modeling Myc Inhibition In Vitro [Poster]
Modeling Myc Inhibition In Vitro [Poster]Modeling Myc Inhibition In Vitro [Poster]
Modeling Myc Inhibition In Vitro [Poster]
 
My PhD Thesis seminar - April 2007
My PhD Thesis seminar - April 2007My PhD Thesis seminar - April 2007
My PhD Thesis seminar - April 2007
 
Sezary syndrome part 2
Sezary syndrome   part 2Sezary syndrome   part 2
Sezary syndrome part 2
 
IPK abstract
IPK abstractIPK abstract
IPK abstract
 
FinalMethodology.docx
FinalMethodology.docxFinalMethodology.docx
FinalMethodology.docx
 
Io combos and the big stick
Io combos and the big stick Io combos and the big stick
Io combos and the big stick
 
Guidelines and techniques for iPSC
Guidelines and techniques for iPSCGuidelines and techniques for iPSC
Guidelines and techniques for iPSC
 
3768 rennert
3768 rennert3768 rennert
3768 rennert
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHD
 
article
articlearticle
article
 
ALETA CNS metastasis program 8 July 2020
ALETA CNS metastasis program 8 July 2020ALETA CNS metastasis program 8 July 2020
ALETA CNS metastasis program 8 July 2020
 
Maslak p.g.-et-al.-2010-blood
Maslak p.g.-et-al.-2010-bloodMaslak p.g.-et-al.-2010-blood
Maslak p.g.-et-al.-2010-blood
 
Building Bridges Between Discovery, Preclinical, And Clinical Research 2008
Building Bridges Between Discovery, Preclinical, And Clinical Research 2008Building Bridges Between Discovery, Preclinical, And Clinical Research 2008
Building Bridges Between Discovery, Preclinical, And Clinical Research 2008
 
AACR poster VP_2014
AACR poster VP_2014AACR poster VP_2014
AACR poster VP_2014
 
The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From ...
The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From ...The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From ...
The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From ...
 

Viewers also liked (6)

Perineal Hernia Animals
Perineal Hernia  AnimalsPerineal Hernia  Animals
Perineal Hernia Animals
 
Canine Rickets
Canine RicketsCanine Rickets
Canine Rickets
 
Intestinal Obstruction, MUDASIR BASHIR
Intestinal Obstruction, MUDASIR BASHIRIntestinal Obstruction, MUDASIR BASHIR
Intestinal Obstruction, MUDASIR BASHIR
 
Neoplasms
NeoplasmsNeoplasms
Neoplasms
 
Preparation Of Surgical Team,Pack And Patient
Preparation Of Surgical Team,Pack And PatientPreparation Of Surgical Team,Pack And Patient
Preparation Of Surgical Team,Pack And Patient
 
GENE THERAPY
GENE THERAPYGENE THERAPY
GENE THERAPY
 

Similar to Six1poster

2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
Simon Gemble
 
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Mohamed Khalid Ali Xundhur
 
1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main
Helene Schulz
 
ResearchDayPosterSpring2016
ResearchDayPosterSpring2016ResearchDayPosterSpring2016
ResearchDayPosterSpring2016
Victor Suarez
 
Provenge (sipuleucel t)
Provenge (sipuleucel t)Provenge (sipuleucel t)
Provenge (sipuleucel t)
Vinblast
 
ISSCR-2014-poster
ISSCR-2014-posterISSCR-2014-poster
ISSCR-2014-poster
Alicia Lee
 
Medullary thyroid carcinoma
Medullary thyroid carcinomaMedullary thyroid carcinoma
Medullary thyroid carcinoma
SoM
 
Provenge (Sipuleucel T)
Provenge (Sipuleucel T)Provenge (Sipuleucel T)
Provenge (Sipuleucel T)
Cytokinine
 

Similar to Six1poster (20)

KI_JBrantley
KI_JBrantleyKI_JBrantley
KI_JBrantley
 
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
2011 - Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 tr...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
JCI0936541
JCI0936541JCI0936541
JCI0936541
 
SNHG7 Expression Is Upregulated in Ovarian Cancer and Promotes Cell Invasion ...
SNHG7 Expression Is Upregulated in Ovarian Cancer and Promotes Cell Invasion ...SNHG7 Expression Is Upregulated in Ovarian Cancer and Promotes Cell Invasion ...
SNHG7 Expression Is Upregulated in Ovarian Cancer and Promotes Cell Invasion ...
 
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
 
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
Gene expression profiling in apoptotic mcf 7 cells infected with newcastle di...
 
Expansion of Human Cord Blood Progenitor Cells Capable of Rapid Myeloid Recon...
Expansion of Human Cord Blood Progenitor Cells Capable of Rapid Myeloid Recon...Expansion of Human Cord Blood Progenitor Cells Capable of Rapid Myeloid Recon...
Expansion of Human Cord Blood Progenitor Cells Capable of Rapid Myeloid Recon...
 
1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main
 
ResearchDayPosterSpring2016
ResearchDayPosterSpring2016ResearchDayPosterSpring2016
ResearchDayPosterSpring2016
 
Xenotransplantation of pig kidney to human
Xenotransplantation of pig kidney to humanXenotransplantation of pig kidney to human
Xenotransplantation of pig kidney to human
 
Sjogren ppt
Sjogren pptSjogren ppt
Sjogren ppt
 
Provenge (sipuleucel t)
Provenge (sipuleucel t)Provenge (sipuleucel t)
Provenge (sipuleucel t)
 
ISSCR-2014-poster
ISSCR-2014-posterISSCR-2014-poster
ISSCR-2014-poster
 
Medullary thyroid carcinoma
Medullary thyroid carcinomaMedullary thyroid carcinoma
Medullary thyroid carcinoma
 
virchowsarch
virchowsarchvirchowsarch
virchowsarch
 
Discovering my research interest by eric garson sheffield university 2017
Discovering my research interest by eric garson   sheffield university 2017Discovering my research interest by eric garson   sheffield university 2017
Discovering my research interest by eric garson sheffield university 2017
 
Provenge (Sipuleucel T)
Provenge (Sipuleucel T)Provenge (Sipuleucel T)
Provenge (Sipuleucel T)
 

Six1poster

  • 1. Assessment of Six1 Expression in Mouse Mammary Tumor Cells Reina Hernandez; Mentor, Michael Cantrell; P.I. Dr. Carla Van Den Berg College of Pharmacy, The University of Texas at Austin Abstract Six 1 is a homeoprotein overexpressed in numerous cancers, where it plays a role in Epithelial-Mesenchymal Transition (EMT) and metastasis. Six1 expression is increased by JNK2 (c-Jun N-terminal kinase 2). Together; JNK2 promotes EMT and Six1 expression in breast cancer cell lines. To determine whether transforming growth factor beta (TGFß) activates JNK2 to increase Six1 expression, cell culture experiments were completed throughout a 24, 48, and 72 hour period. P53: jnk2ko GFP-JNK2 cancer cells were treated with serum free media alone or with TGFß, fetal bovine serum, and fibroblast growth factor-alpha added. Throughout the 24- 48 hour period, cells were harvested and Western blot analysis was used to determine the protein expression of Six1. Growth of mouse mammary tumor cells was seen in a 24 to 72 hour period, and changes in morphology were noted. PCR was also completed to establish a standard curve that could be used in future qPCR experiments using samples from the Six1 cell culture experiments. Unexpectedly, multiple bands showed that there may be changes in Six1 phosphorylation in addition to potential expression differences. To better understand the mechanisms behind Six1 expression and JNK2, further experiments are required. (1) Six1 expression cell culture experiments completed throughout a 24, 48, and 72 hour period. P53:jnk2ko GFP-JNK2 cancer cells were treated with SFM, TGFß, 10%FBS, and ∂FGF. Increased proliferation of mouse mammary tumor cells are seen in the 24-72 hour period. Cells in 24-hour samples are cuboidal; by contrast cells in 72-hour samples are more spindle shaped morphology and are not contact inhibited in the TGFβ sample. (3,4,5) Western blot analysis of 24-72 hour period of P53: jnk2ko GFP-JNK2 cells was completed and tested with Beta-Tubulin as a loading control. Unexpectedly, we observed that Six1 protein migrates as multiple bands in some treatments, indicating that it may be phosphorylated in proliferating cells. The presence of multiple bands prevented accurate quantification of total Six1 protein expression (2,6) Figure 2. PCR that was completed on Six1. This experiment resulted in an optimum annealing temperature 52-53.5 degrees that was used to construct a standard curve with varying concentrations by future qPCR experiments. Results Results ContinuedMethods 1. 2. 3. 6. 4. Conclusion/Discussion While changes in Six1 protein expression was not determined, we did observed that Six1 undergoes post- tranlastional changes consistent with phosphorylation in response to growth factor treatments. Human Six1 has been demonstrated as “a nuclear phosphoprotein that becomes hyperphosphorylated at mitosis.” (Ford, et. al. 2000) This can account for the multiple Six1 bands in response to treatment. We also observed a change in cell morphology. Mouse mammary tumor cells from the 24-hour period were cuboidal, by comparison to the 72 hour treated cells, which appear more spindle-like, consistent with EMT. PCR optimization provided ideal annealing temperatures that will be used to construct a standard curve for qPCR experiments. Six1 and JNK2’s role in the events leading to EMT will be tested using jnk2 knockout cells. Introduction There are three c-Jun N-terminal kinase (jnk) genes (jnk1-3) that are expressed in mice and humans. The Van Den Berg lab studies JNK2 breast cancer, and have previously shown that JNK2 regulates Epithelial to Mesenchymal Transition (EMT) and Six1, a regulator of EMT. Because TGFß promotes Six1 expression, we hypothesized that EMT is induced through the pathway as shown in Figure 1. Acknowledgements This project was supported by The University of Texas System Louis Stokes Alliance for Minority Participation (LSAMP) and funded by The National Science Foundation Special thanks to Dr. Van Den Berg and to all members of the Van Den Berg Lab Figure 1. 5. References Heide L. Ford, Esther Landesman-Bollag, Caroline S. Dacwag, P. Todd Stukenberg, Arthur B. Pardee, and David C. Seldin. “Cell Cycle-regulated Phosphorylation of the Human SIX1 Homeodomain Protein.” JBC Papers (2000). DOI 10.1074/jbc. M002446200